In this special edition of Eagle’s Eye View, Dr. Eagle looks four of the most important trials presented at the recent TCT Conference: 1) EARLY TAVR evaluating TAVR compared to clinical surveillance; ...

These technologies produced some of the biggest cardiovascular stories at TCT 2024. Top, from left: Boston Scientific’s Acurate neo2, Inari Medical’s FlowTriever, Edwards’ Evoque valve.

Edwards Lifesciences, Medtronic and Inari Medical used this week’s Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, D.C., to share clinical trial data on their devices. Read ...

WASHINGTON, D.C.—Johnson & Johnson MedTech’s Abiomed announced that its compressible, expandable heart pump has cleared a pivotal trial, and it’s now headed for FDA review in the coming months.

The ECLIPSE trial, presented as a late-breaking study at the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, D.C., had enrolled ...

TCT 1564: Stopping the Flow: Endovascular Coil Embolization of an Iatrogenic Aorto-Coronary Vein Fistula Causing High-Output Heart Failure and Cardiogenic Shock Receive the the latest news, research, ...

These outcomes were presented today at the Transcatheter Cardiovascular Therapeutics (TCT) conference by Professor Hélène Eltchaninoff, Head of the Cardiology Department at Rouen University Hospital, ...

Investigators presented results at Transcatheter Cardiovascular Therapeutics (TCT) 2024 in Washington, D.C. Dr. Amir Kaki led the FDA IDE study — the first completed pivotal trial for Impella ...

In JACC, Koshiro Sakai, MD, PhD, et al., evaluated the clinical impact and diagnostic performance of PCD-CT compared with conventional energy-integrating detector computed tomography for treating ...

Get the latest news and updates from TCTMD. Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research ...